{"id":"https://openalex.org/W7126423347","doi":"https://doi.org/10.1002/slct.202505304","title":"Aryloxyethylamines Chalcones as Potential \u03b23 AR Binders: Synthesis, In Vivo Antidiabetic and Molecular Modeling Studies","display_name":"Aryloxyethylamines Chalcones as Potential \u03b23 AR Binders: Synthesis, In Vivo Antidiabetic and Molecular Modeling Studies","publication_year":2026,"publication_date":"2026-01-31","ids":{"openalex":"https://openalex.org/W7126423347","doi":"https://doi.org/10.1002/slct.202505304"},"language":"en","primary_location":{"id":"doi:10.1002/slct.202505304","doi":"https://doi.org/10.1002/slct.202505304","is_oa":false,"landing_page_url":"https://doi.org/10.1002/slct.202505304","pdf_url":null,"source":{"id":"https://openalex.org/S4210221416","display_name":"ChemistrySelect","issn_l":"2365-6549","issn":["2365-6549"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","ki-jl-1","norway-1","poland-40","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ChemistrySelect","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5084469047","display_name":"Ashish Srivastava","orcid":"https://orcid.org/0000-0001-9159-9466","observed_orcids":["https://orcid.org/0000-0001-9159-9466"]},"institutions":[{"id":"https://openalex.org/I4405287327","display_name":"Pranveer Singh Institute of Technology (Pharmacy), Kanpur","ror":"https://ror.org/04v8v3741","country_code":"IN","type":"education","lineage":["https://openalex.org/I4405287327"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Ashish Srivastava","raw_affiliation_strings":["PSIT\u2010Pranveer Singh Institute of Technology (Pharmacy)  Kanpur Uttar Pradesh India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PSIT\u2010Pranveer Singh Institute of Technology (Pharmacy)  Kanpur Uttar Pradesh India","institution_ids":["https://openalex.org/I4405287327"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5124481059","display_name":"Law Kumar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I116130893","display_name":"Veer Kunwar Singh University","ror":"https://ror.org/05gypvt76","country_code":"IN","type":"education","lineage":["https://openalex.org/I116130893"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Law Kumar","raw_affiliation_strings":["P. G. Department of Chemistry Veer Kunwar Singh University  Bhojpur Bihar India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"P. G. Department of Chemistry Veer Kunwar Singh University  Bhojpur Bihar India","institution_ids":["https://openalex.org/I116130893"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102171554","display_name":"Parul Srivastava","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405287327","display_name":"Pranveer Singh Institute of Technology (Pharmacy), Kanpur","ror":"https://ror.org/04v8v3741","country_code":"IN","type":"education","lineage":["https://openalex.org/I4405287327"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Parul Srivastava","raw_affiliation_strings":["PSIT\u2010Pranveer Singh Institute of Technology (Pharmacy)  Kanpur Uttar Pradesh India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PSIT\u2010Pranveer Singh Institute of Technology (Pharmacy)  Kanpur Uttar Pradesh India","institution_ids":["https://openalex.org/I4405287327"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111201611","display_name":"Poonam Shukla","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I116130893","display_name":"Veer Kunwar Singh University","ror":"https://ror.org/05gypvt76","country_code":"IN","type":"education","lineage":["https://openalex.org/I116130893"]}],"countries":["IN"],"is_corresponding":true,"raw_author_name":"Poonam Shukla","raw_affiliation_strings":["P. G. Department of Chemistry Veer Kunwar Singh University  Bhojpur Bihar India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"P. G. Department of Chemistry Veer Kunwar Singh University  Bhojpur Bihar India","institution_ids":["https://openalex.org/I116130893"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5010723907","display_name":"Minhajul Arfeen","orcid":"https://orcid.org/0000-0002-7255-5254","observed_orcids":["https://orcid.org/0000-0002-7255-5254"]},"institutions":[{"id":"https://openalex.org/I156216236","display_name":"Qassim University","ror":"https://ror.org/01wsfe280","country_code":"SA","type":"education","lineage":["https://openalex.org/I156216236"]}],"countries":["SA"],"is_corresponding":true,"raw_author_name":"Minhajul Arfeen","raw_affiliation_strings":["Department of Medicinal Chemistry and Pharmacognosy, College of Pharmacy Qassim University  Buraydah Saudia Arabia"],"raw_orcid":"https://orcid.org/0000-0002-7255-5254","affiliations":[{"raw_affiliation_string":"Department of Medicinal Chemistry and Pharmacognosy, College of Pharmacy Qassim University  Buraydah Saudia Arabia","institution_ids":["https://openalex.org/I156216236"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5010723907","https://openalex.org/A5111201611"],"corresponding_institution_ids":["https://openalex.org/I116130893","https://openalex.org/I156216236"],"apc_list":{"value":3880,"currency":"USD","value_usd":3880},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.03554612,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"11","issue":"5","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.9589999914169312,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.9589999914169312,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11140","display_name":"Natural Antidiabetic Agents Studies","score":0.03480000048875809,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chalcones","display_name":"chalcones","score":0.8949999809265137},{"id":"https://openalex.org/keywords/beta3-adrenergic-receptor","display_name":"beta3-adrenergic receptor","score":0.847000002861023},{"id":"https://openalex.org/keywords/antidiabetic-activity","display_name":"antidiabetic activity","score":0.875},{"id":"https://openalex.org/keywords/streptozotocin-induced-diabetes","display_name":"streptozotocin-induced diabetes","score":0.9620000123977661},{"id":"https://openalex.org/keywords/glucose-tolerance-test","display_name":"glucose tolerance test","score":0.796999990940094},{"id":"https://openalex.org/keywords/molecular-docking","display_name":"molecular docking","score":0.8330000042915344},{"id":"https://openalex.org/keywords/binding-affinity","display_name":"binding affinity","score":0.5},{"id":"https://openalex.org/keywords/insulin-resistance","display_name":"insulin resistance","score":0.5550000071525574},{"id":"https://openalex.org/keywords/carazolol","display_name":"carazolol","score":0.6460000276565552},{"id":"https://openalex.org/keywords/hydrophobic-interactions","display_name":"hydrophobic interactions","score":0.7049999833106995}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.7990000247955322},{"id":"https://openalex.org/C112887158","wikidata":"https://www.wikidata.org/wiki/Q169324","display_name":"Hydrogen bond","level":3,"score":0.7562000155448914},{"id":"https://openalex.org/C2778678469","wikidata":"https://www.wikidata.org/wiki/Q411119","display_name":"Ethylamine","level":2,"score":0.642300009727478},{"id":"https://openalex.org/C178910836","wikidata":"https://www.wikidata.org/wiki/Q2196961","display_name":"Molecular model","level":2,"score":0.6000999808311462},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.5911999940872192},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.53329998254776},{"id":"https://openalex.org/C90260826","wikidata":"https://www.wikidata.org/wiki/Q899157","display_name":"Hydrophobic effect","level":2,"score":0.5054000020027161},{"id":"https://openalex.org/C41685203","wikidata":"https://www.wikidata.org/wiki/Q1974042","display_name":"Docking (animal)","level":2,"score":0.5012999773025513},{"id":"https://openalex.org/C204921945","wikidata":"https://www.wikidata.org/wiki/Q899689","display_name":"Side chain","level":3,"score":0.4422000050544739},{"id":"https://openalex.org/C2780378348","wikidata":"https://www.wikidata.org/wiki/Q25351438","display_name":"Ring (chemistry)","level":2,"score":0.4153999984264374},{"id":"https://openalex.org/C116569031","wikidata":"https://www.wikidata.org/wiki/Q899107","display_name":"Ligand (biochemistry)","level":3,"score":0.3873000144958496},{"id":"https://openalex.org/C107824862","wikidata":"https://www.wikidata.org/wiki/Q616005","display_name":"Binding site","level":2,"score":0.3278999924659729},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2802000045776367},{"id":"https://openalex.org/C2910068830","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 Diabetes Mellitus","level":3,"score":0.27230000495910645},{"id":"https://openalex.org/C193042331","wikidata":"https://www.wikidata.org/wiki/Q1772003","display_name":"Structure\u2013activity relationship","level":3,"score":0.26089999079704285},{"id":"https://openalex.org/C51639874","wikidata":"https://www.wikidata.org/wiki/Q167149","display_name":"Plasma protein binding","level":2,"score":0.25429999828338623},{"id":"https://openalex.org/C41183919","wikidata":"https://www.wikidata.org/wiki/Q423026","display_name":"Active site","level":3,"score":0.2515000104904175}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1002/slct.202505304","doi":"https://doi.org/10.1002/slct.202505304","is_oa":false,"landing_page_url":"https://doi.org/10.1002/slct.202505304","pdf_url":null,"source":{"id":"https://openalex.org/S4210221416","display_name":"ChemistrySelect","issn_l":"2365-6549","issn":["2365-6549"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","ki-jl-1","norway-1","poland-40","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ChemistrySelect","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.8560000061988831,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":52,"referenced_works":["https://openalex.org/W1964275977","https://openalex.org/W1970959987","https://openalex.org/W1989578166","https://openalex.org/W1995343510","https://openalex.org/W1998860843","https://openalex.org/W2016458036","https://openalex.org/W2021705867","https://openalex.org/W2028944925","https://openalex.org/W2038517682","https://openalex.org/W2049502419","https://openalex.org/W2065547659","https://openalex.org/W2067399095","https://openalex.org/W2083417204","https://openalex.org/W2101343004","https://openalex.org/W2105668062","https://openalex.org/W2127277443","https://openalex.org/W2134967712","https://openalex.org/W2157236165","https://openalex.org/W2164410780","https://openalex.org/W2412869619","https://openalex.org/W2773037751","https://openalex.org/W2789406299","https://openalex.org/W2804803233","https://openalex.org/W2894471886","https://openalex.org/W2921636259","https://openalex.org/W2961328380","https://openalex.org/W2999423635","https://openalex.org/W3001593379","https://openalex.org/W3015022543","https://openalex.org/W3113730240","https://openalex.org/W3121516100","https://openalex.org/W3154210377","https://openalex.org/W3183212206","https://openalex.org/W3190135421","https://openalex.org/W3200561328","https://openalex.org/W4200026682","https://openalex.org/W4386987639","https://openalex.org/W4388039163","https://openalex.org/W4388303344","https://openalex.org/W4389085392","https://openalex.org/W4392243593","https://openalex.org/W4393357031","https://openalex.org/W4396545756","https://openalex.org/W4400514139","https://openalex.org/W4403442173","https://openalex.org/W4409120311","https://openalex.org/W4410193554","https://openalex.org/W4411929190","https://openalex.org/W4413296198","https://openalex.org/W4415112514","https://openalex.org/W7077056112","https://openalex.org/W7081918473"],"related_works":["https://openalex.org/W2749657236","https://openalex.org/W2028944925","https://openalex.org/W1996287193","https://openalex.org/W2998298946","https://openalex.org/W4411694822","https://openalex.org/W2055011154","https://openalex.org/W2037343994","https://openalex.org/W2079901978","https://openalex.org/W2583424820","https://openalex.org/W3191708844"],"abstract_inverted_index":{"ABSTRACT":[0],"Diabetes":[1],"mellitus":[2],"is":[3],"a":[4,233],"progression":[5],"involves":[6],"worsening":[7],"insulin":[8],"resistance":[9],"and":[10,25,36,51,66,80,84,90,92,125,138,144,151,159,173,195,208,225,260],"\u03b2\u2010cell":[11],"dysfunction,":[12],"culminating":[13],"in":[14,64,70,72,88,94,117,180,187,232,255],"severe":[15],"metabolic":[16],"complications.":[17],"In":[18],"this":[19],"work,":[20],"chalcone\u2010based":[21],"aryloxyethylamines":[22],"were":[23],"synthesized":[24],"evaluated":[26],"for":[27,102],"their":[28],"antihyperglycemic":[29],"activity":[30,58],"using":[31],"glucose":[32,86],"tolerance":[33],"test":[34],"(GTT)":[35],"STZ\u2010induced":[37,95],"DM":[38,96],"rat":[39,97],"models.":[40,74],"Compounds":[41],"12":[42,81,152,174,196,244,261],",":[43,45,47,49],"10":[44,79,150,172,188,194,218,259],"8":[46],"7":[48],"5,":[50],"3":[52],"exhibited":[53,82],"moderate":[54],"to":[55,62,68,112,122,127,182],"good":[56],"anti\u2010DM":[57],"ranging":[59],"from":[60],"18.5%":[61],"39.8%":[63,85],"GTT":[65,89],"11.6%":[67],"28.3%":[69,91],"STZ":[71],"vivo":[73],"The":[75,146,163,210,239],"most":[76,147],"promising":[77,148],"compounds":[78,111],"31.1%":[83],"lowering":[87],"22.9%":[93],"model,":[98],"respectively.":[99,162],"Molecular":[100],"docking":[101,115],"\u03b23\u2010AR":[103,264],"revealed":[104],"strong":[105],"binding":[106,155,164],"affinity":[107],"of":[108,120,157,171,193,217,243,258],"the":[109,118,154,198,252,256],"identified":[110],"\u03b23\u2010AR,":[113],"with":[114,136,141,178,185,222,237,249],"scores":[116],"range":[119],"\u22127.8":[121],"\u22128.9":[123,158],"kcal/mol":[124],"comparable":[126],"co\u2010crystallized":[128],"ligand":[129],"carazolol.":[130],"Key":[131],"interactions":[132,221],"included":[133],"hydrogen":[134,176,183,235,247],"bonds":[135],"Asn312":[137],"hydrophobic":[139,200,220],"contacts":[140],"Val118,":[142,207],"Val121,":[143],"Phe309.":[145],"compound":[149],"displayed":[153,175,219,245],"score":[156],"\u22128.1":[160],"kcal/mol,":[161],"mode":[165],"analysis":[166],"showed":[167],"that":[168],"carbonyl":[169],"oxygen":[170],"bond":[177,184,236,248],"Asn312,":[179],"addition":[181],"Ser209":[186],".":[189],"Further,":[190],"ring":[191,215,228],"A":[192],"occupied":[197],"aromatic":[199],"core":[201],"created":[202],"by":[203],"residues":[204],"Phe308,":[205],"Phe309,":[206],"Val121.":[209],"ethylamine":[211,240],"side":[212,241],"chain":[213,242],"on":[214],"B":[216,229],"Val205,":[223],"Ala316,":[224],"Arg315,":[226],"while":[227],"itself":[230],"engages":[231],"carbon":[234,246],"Tyr204.":[238],"Asn332.":[250],"Overall,":[251],"work":[253],"resulted":[254],"identification":[257],"as":[262],"potential":[263],"binders.":[265]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2026-02-02T00:00:00"}